Firefly Neuroscience, Inc.(AIFF)Earnings, Financials & Key Ratios
AIFF•NASDAQ
$1.28
Price updated Jul 6, 2026
AboutFirefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.Show more
- Revenue$1M+957.4%
- EBITDA-$8M+7.5%
- Net Income-$20M-90.1%
- EPS (Diluted)-1.82-13.7%
- Gross Margin56.48%+48.8%
- EBITDA Margin-738.44%+91.2%
- Operating Margin-753.5%+91.1%
- Net Margin-1740.98%+82.0%
- ROE-547.56%
AIFF Price & Volume
Firefly Neuroscience, Inc. (AIFF) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operational Losses Challenge Firefly Neuroscience Viability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Critical liquidity runway depletion
Key Thesis Takeaways
- Firefly Neuroscience faces a precarious fundamental outlook characterized by erratic, project-based revenue streams and a significant misalignment between operating expenses and commercial output.
- The company's reliance on intangible assets, specifically $5.2 million in goodwill, combined with a ballooning accumulated deficit of $113.6 million, raises substantial concerns regarding long-term solvency.
- Investors should monitor the company's ability to secure non-dilutive funding, as the current cash burn rate threatens to exhaust the remaining $3.1 million in liquidity without a clear path to sustainable profitability.
Verdict Logic
the company's precarious liquidity buffer of $3.1 million against a persistent quarterly net loss of $2.0 million in 2026Q1 suggests a high probability of near-term dilutive financing.
AIFF Growth Metrics
Firefly Neuroscience, Inc. (AIFF) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-39.34%
3 Years-
TTM-22.07%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM58.14%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM76.49%
Return on Capital
10 Years-1013.08%
5 Years-1530.08%
3 Years-1530.08%
Last Year-236.3%
AIFF Recent Earnings
Firefly Neuroscience, Inc. (AIFF) EPS & revenue vs analyst estimates — last 4 quarters
Q3 2026Latest
Jun 30, 2026Metric
Actual
Est
EPS
$0.13
—
Rev
$485,000
—
Q2 2026
May 12, 2026Metric
Actual
Est
EPS
$0.13
—
Rev
$412,000
—
Q4 2025
Nov 12, 2025Metric
Actual
Est
EPS
$0.20
—
Rev
$388,000
—
Q3 2025
Aug 13, 2025Metric
Actual
Est
EPS
$0.14
—
Rev
$299,000
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 30, 2026 | $0.13 | $485,000 |
| Q2 2026 | May 12, 2026 | $0.13 | $412,000 |
| Q4 2025 | Nov 12, 2025 | $0.20 | $388,000 |
| Q3 2025 | Aug 13, 2025 | $0.14 | $299,000 |
Based on last 12 quarters of dataView full earnings history →
Peers Comparison
Key metrics vs top competitors for Firefly Neuroscience, Inc. (AIFF)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.28 | $19.98M | -0.70 | 957.41% | -1740.98% | -547.56% | — | |
| $2.40 | $98.99M | -0.08 | — | — | — | — | |
| $3.95 | $68.19M | -2.94 | — | -1070.26% | — | — | |
| $1.10 | $33.97M | -0.19 | -71.67% | -11078.53% | — | — | |
| $9.35 | $1.54B | 3.68 | 64.69% | -14.73% | — | — | |
| $242.60 | $12.48B | -65.92 | 65.55% | -26.59% | -260.01% | — |
Compare AIFF vs Peers
Firefly Neuroscience, Inc. (AIFF) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when AIFF posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
AIFF Frequently Asked Questions
Firefly Neuroscience, Inc. (AIFF) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Firefly Neuroscience, Inc.'s revenue?
Firefly Neuroscience, Inc. (AIFF) reported $1.6M in revenue for fiscal year 2025. This represents a 89% decrease from $13.9M in 2020.
How fast is Firefly Neuroscience, Inc. growing?
Firefly Neuroscience, Inc. (AIFF) grew revenue by 957.4% over the past year. This is strong growth.
Is AIFF profitable?
Firefly Neuroscience, Inc. (AIFF) reported a net loss of $9.0M for fiscal year 2025.
Dividend & Returns
What is AIFF's return on equity?
Firefly Neuroscience, Inc. (AIFF) has a return on equity (ROE) of -547.6%. Negative ROE indicates the company is unprofitable.
What is Firefly Neuroscience, Inc.'s free cash flow?
Firefly Neuroscience, Inc. (AIFF) had negative free cash flow of $7.8M in fiscal year 2025, likely due to heavy capital investments.